Abstract
Extracellular Gram-negative pathogenic bacteria target essential cytoplasmic processes of eukaryotic cells by using effector protein delivery systems such as the type III secretion system (T3SS). These secretion systems directly inject effector proteins into the host cell cytoplasm. Among the T3SS-dependent Yop proteins of pathogenic Yersinia, the function of the effector protein YopM remains enigmatic. In a recent study, we demonstrated that recombinant YopM from Yersinia enterocolitica enters host cells autonomously without the presence of bacteria and thus identified YopM as a novel bacterial cell-penetrating protein. Following entry YopM down-regulates expression of pro-inflammatory cytokines such as tumor necrosis factor α. These properties earmark YopM for further development as a novel anti-inflammatory therapeutic. To elucidate the uptake and intracellular targeting mechanisms of this bacterial cell-penetrating protein, we analyzed possible routes of internalization employing ultra-cryo electron microscopy. Our results reveal that under physiological conditions, YopM enters cells predominantly by exploiting endocytic pathways. Interestingly, YopM was detected free in the cytosol and inside the nucleus. We could not observe any colocalization of YopM with secretory membranes, which excludes retrograde transport as the mechanism for cytosolic release. However, our findings indicate that direct membrane penetration and/or an endosomal escape of YopM contribute to the cytosolic and nuclear localization of the protein. Surprisingly, even when endocytosis is blocked, YopM was found to be associated with endosomes. This suggests an intracellular endosome-associated transport of YopM.








Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.Abbreviations
- CCV:
-
Clathrin-coated vesicles
- CF:
-
Cytosolic fraction
- CPP:
-
Cell-penetrating protein
- CYT:
-
Cytosol
- E:
-
Endosomes
- EE:
-
Early endosome
- ER:
-
Endoplasmic reticulum
- GA:
-
Golgi apparatus
- HM:
-
Heavy membranes
- LE:
-
Late endosome
- LYS:
-
Lysosome
- MITO:
-
Mitochondria
- MVB:
-
Multi-vesicular-bodies
- nCCV:
-
Non-clathrin-coated vesicles
- N:
-
Nucleus
- NE:
-
Nuclear envelope
- NF:
-
Nuclear fraction
- PM:
-
Plasma membrane
- PNS:
-
Post-nuclear supernatant
- PTD:
-
Protein transduction domain
- SE:
-
Sorting endosome
- TC:
-
Transport carrier
- TGN:
-
Trans-Golgi network
- YopM:
-
Yersinia outer protein M
References
Forsberg A, Viitanen AM, Skurnik M, Wolf-Watz H (1991) The surface-located YopN protein is involved in calcium signal transduction in Yersinia pseudotuberculosis. Mol Microbiol 5:977–986
Straley SC, Bowmer WS (1986) Virulence genes regulated at the transcriptional level by Ca2 + in Yersinia pestis include structural genes for outer membrane proteins. Infect Immun 51:445–454
Boland A, Havaux S, Cornelis GR (1998) Heterogeneity of the Yersinia YopM protein. Microb Pathog 25:343–348
Skrzypek E, Cowan C, Straley SC (1998) Targeting of the Yersinia pestis YopM protein into HeLa cells and intracellular trafficking to the nucleus. Mol Microbiol 30:1051–1065
Benabdillah R, Mota LJ, Lützelschwab S, Demoinet E, Cornelis GR (2004) Identification of a nuclear targeting signal in YopM from Yersinia spp. Microb Pathog 36:247–261
Kerschen EJ, Cohen DA, Kaplan AM, Straley SC (2004) The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells. Infect Immun 72:4589–4602
Ye Z, Uittenbogaard AM, Cohen DA, Kaplan AM, Ambati J et al (2011) Distinct CCR2(+) Gr1(+) cells control growth of the Yersinia pestis ΔyopM mutant in liver and spleen during systemic plague. Infect Immun 79:674–687
Rüter C, Buss C, Scharnert J, Heusipp G, Schmidt MA (2010) A newly identified bacterial cell-penetrating peptide that reduces the transcription of pro-inflammatory cytokines. J Cell Sci 123:2190–2198
Kilk K, Langel U (2005) Cellular delivery of peptide nucleic acid by cell-penetrating peptides. Methods Mol Biol 298:131–141
Holm T, Andaloussi SE, Langel U (2011) Comparison of CPP uptake methods. Methods Mol Biol 683:207–217
Richard JP, Melikov K, Brooks H, Prevot P, Lebleu B et al (2005) Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J Biol Chem 280:15300–15306
Fischer R, Fotin-Mleczek M, Hufnagel H, Brock R (2005) Break on through to the other side-biophysics and cell biology shed light on cell-penetrating peptides. Chem BioChem 6:2126–2142
Kaplan IM, Wadia JS, Dowdy SF (2005) Cationic TAT peptide transduction domain enters cells by macropinocytosis. J Control Release 102:247–253
Wadia JS, Stan RV, Dowdy SF (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 10:310–315
Säälik P, Padari K, Niinep A, Lorents A, Hansen M et al (2009) Protein delivery with transportans is mediated by caveolae rather than flotillin-dependent pathways. Bioconjug Chem 20:877–887
Duchardt F, Fotin-Mleczek M, Schwarz H, Fischer R, Brock R (2007) A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic 8:848–866
Tünnemann G, Martin RM, Haupt S, Patsch C, Edenhofer F et al (2006) Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells. FASEB J 20:1775–1784
Heusipp G, Spekker K, Brast S, Fälker S, Schmidt MA (2006) YopM of Yersinia enterocolitica specifically interacts with alpha1-antitrypsin without affecting the anti-protease activity. Microbiology 152:1327–1335
el Bayâ A, Linnermann R, von Olleschik-Elbheim L, Schmidt MA (1997) Pertussis toxin. Entry into cells and enzymatic activity. Adv Exp Med Biol 419:83–86
Mari M, Bujny MV, Zeuschner D, Geerts WJ, Griffith J et al (2008) SNX1 defines an early endosomal recycling exit for sortilin and mannose 6-phosphate receptors. Traffic 9:380–393
Langel Ü (2005) Handbook of cell-penetrating peptides. CRC Press, Taylor & Francis Group, Boca Raton
Gorvel JP, Chavrier P, Zerial M, Gruenberg J (1991) rab5 controls early endosome fusion in vitro. Cell 64:915–925
Brown E, Verkade P (2010) The use of markers for correlative light electron microscopy. Protoplasma 244:91–97
Hutagalung AH, Novick PJ (2011) Role of Rab GTPases in membrane traffic and cell physiology. Physiol Rev 91:119–149
Rink J, Ghigo E, Kalaidzidis Y, Zerial M (2005) Rab conversion as a mechanism of progression from early to late endosomes. Cell 122:735–749
Lombardi D, Soldati T, Riederer MA, Goda Y, Zerial M et al (1993) Rab9 functions in transport between late endosomes and the trans Golgi network. EMBO J 12:677–682
Goud B, Zahraoui A, Tavitian A, Saraste J (1990) Small GTP-binding protein associated with Golgi cisternae. Nature 345:553–556
Trabulo S, Resina S, Simões S, Lebleu B, Pedroso de Lima MC (2010) A non-covalent strategy combining cationic lipids and CPPs to enhance the delivery of splice correcting oligonucleotides. J Control Release 145:149–158
Ter-Avetisyan G, Tünnemann G, Nowak D, Nitschke M, Herrmann A et al (2009) Cell entry of arginine-rich peptides is independent of endocytosis. J Biol Chem 284:3370–3378
Jiao CY, Delaroche D, Burlina F, Alves ID, Chassaing G et al (2009) Translocation and endocytosis for cell-penetrating peptide internalization. J Biol Chem 284:33957–33965
Weigel PH, Oka JA (1981) Temperature dependence of endocytosis mediated by the asialoglycoprotein receptor in isolated rat hepatocytes. Evidence for two potentially rate-limiting steps. J Biol Chem 256:2615–2617
Letoha T, Gaál S, Somlai C, Czajlik A, Perczel A et al (2003) Membrane translocation of penetratin and its derivatives in different cell lines. J Mol Recognit 16:272–279
Padari K, Säälik P, Hansen M, Koppel K, Raid R et al (2005) Cell transduction pathways of transportans. Bioconjug Chem 16:1399–1410
Frankel AD, Pabo CO (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55:1189–1193
Green M, Loewenstein PM (1988) Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55:1179–1188
Medina-Kauwe LK (2007) Alternative endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery? Adv Drug Deliv Rev 59:798–809
Derossi D, Calvet S, Trembleau A, Brunissen A, Chassaing G et al (1996) Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J Biol Chem 271:18188–18193
Heitz F, Morris MC, Divita G (2009) Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br J Pharmacol 157:195–206
Lesser CF, Miller SI (2001) Expression of microbial virulence proteins in Saccharomyces cerevisiae models mammalian infection. EMBO J 20:1840–1849
Acknowledgments
This study was supported in part by the Graduate Program “Cell Dynamics and Disease (CEDAD)” of the Westfälische Wilhelms-Universität Münster (9817300 to J. S.) and by the Deutsche Forschungsgemeinschaft (Graduiertenkolleg GRK 1409) (209657 to M. A. S. and M.-L. L.) and by a grant of the Innovative Medizinische Forschung (IMF) (I-RÜ11106 to C. R.). This study is part of the PhD thesis of J. S. and M.-L. L.
Author information
Authors and Affiliations
Corresponding author
Additional information
M. A. Schmidt and C. Rüter contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
18_2013_1413_MOESM1_ESM.tif
Fig. S1 Non-penetrative YopM87-C lacking the PTD of YopM is not taken up at 4°C. Immunoblot of HeLa membrane fractionation after incubation with YopM87-C at 4°C and 37°C. Membranes were separated using a discontinuous sucrose flotation gradient. The purity of the fractions was assessed by using marker proteins for different cellular compartments. At 37°C YopM87-C localized in the endosomal and heavy membrane fraction, whereas at 4°C no YopM87-C was detectable in these fraction. E, endosomes; HM, heavy membranes; PNS, post nuclear supernatant; PDI, protein disulfide isomerase; TfR, transferrin receptor (TIFF 507 kb)
18_2013_1413_MOESM2_ESM.tif
Fig. S2 Removal of cell surface proteins by proteinase K does not abolish membrane translocation of YopM. HeLa cells were treated with 500 μg/ml proteinase K for 15 min prior to YopM (25 μg/ml) incubation. a, b FACS analysis of HeLa cells incubated with YopM-Cy3 for a total of 1 h (a). Successful removal of cell surface proteins (e.g. TfR) was tested by measuring internalization of Alexa 488-labeled transferrin (b). Samples were taken at indicated time points and trypan blue (final concentration 0.2 %) was added directly before measurement to quench extracellular fluorescence. The number of analyzed cells is plotted against the mean fluorescence intensity measured for each cell. Furthermore, overlay of histogram plots from cells incubated for 15 min with YopM-Cy3 or TF-Alexa 488 after removal of surface proteins by proteinase K are depicted. c Immunoblot of subcellular fractionations of HeLa cells incubated with YopM at 37°C for 1 h. In order to assess their purity, fractions were analyzed using antibodies against α-Tubulin and LSD1. YopM partition was assessed using a YopM-specific polyclonal antibody. CF, cytosolic fraction; LSD1, Lysine-specific demethylase 1; NF, nuclear fraction; PK, proteinase K; TfR, transferrin receptor (TIFF 1043 kb)
18_2013_1413_MOESM3_ESM.tif
Fig. S3 Low temperature does not effect plasma membrane integrity of HeLa cells. To analyze membrane integrity of HeLa cells at 4°C cells were incubated with propidium iodide (1 μg/ml) on ice for a total of 1 h with or without YopM-Alexa 488 (25 μg/ml). The number of analyzed cells is plotted against the mean fluorescence intensity of propium iodide measured for each cell (TIFF 7895 kb)
Rights and permissions
About this article
Cite this article
Scharnert, J., Greune, L., Zeuschner, D. et al. Autonomous translocation and intracellular trafficking of the cell-penetrating and immune-suppressive effector protein YopM. Cell. Mol. Life Sci. 70, 4809–4823 (2013). https://doi.org/10.1007/s00018-013-1413-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-013-1413-2
